Retrospective analysis of clinical outcome of benign and malignant salavary gland tumors

Recruiting

• Conditions: D37.0; C07; C06.9; C08.9; Lip, oral cavity and pharynx; Malignant neoplasm of parotid gland; Mouth, unspecified; Major salivary gland, unspecified

• Registration Number: DRKS00027578
• Lead Sponsor: niklinik Freiburg Klinik für Mund-, Kiefer- und Gesichtschirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Primarily surgically treated patients with benign and malignant salivary gland tumors, initial diagnosis 01/01/2000 - 31/12/2015

Exclusion Criteria

Other tumor entities (e.g., squamous cell carcinoma of the oral mucosa); Patients treated primarily with radio (chemo) therapy, primary tumor with operation alio loco.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence of recurrence or secondary metastasis after surgical treatment of the tumor.

Secondary Outcome Measures

Name	Time	Method
Occurrence of facial palsy. Occurrence of secondary tumors.